Today's Daily Dose brings you news about FDA panel vote on Paratek Pharma's antibiotic Omadacycline; Rite Aid calling off merger with privately held Albertsons Companies; United Therapeutics' settlement of patent litigation with Watson Laboratories Inc., relating to Tyvaso; Otonomy's anticipated events, and second quarter financial results of Nektar and Novavax.
from RTT - Biotech https://ift.tt/2MsnLxF
via IFTTT
No comments:
Post a Comment